ID: ALA3663573

Max Phase: Preclinical

Molecular Formula: C24H25F3N6O2

Molecular Weight: 486.50

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cccc(-c2c(C)cnn2C)c1C(=O)N1C2CCC1C(Nc1cnc(C(F)(F)F)cn1)C2

Standard InChI:  InChI=1S/C24H25F3N6O2/c1-13-10-30-32(2)22(13)15-5-4-6-18(35-3)21(15)23(34)33-14-7-8-17(33)16(9-14)31-20-12-28-19(11-29-20)24(25,26)27/h4-6,10-12,14,16-17H,7-9H2,1-3H3,(H,29,31)

Standard InChI Key:  FQGVMFCTXQTZLC-UHFFFAOYSA-N

Associated Targets(Human)

Orexin receptor 2 5902 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Orexin receptor 1 669 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 486.50Molecular Weight (Monoisotopic): 486.1991AlogP: 4.07#Rotatable Bonds: 5
Polar Surface Area: 85.17Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 1.92CX LogP: 2.79CX LogD: 2.79
Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.59Np Likeness Score: -0.81

References

1.  (2015)  Substituted 7-azabicyles and their use as orexin receptor modulators, 
2.  (2016)  Substituted 7-azabicycles and their use as orexin receptor modulators, 

Source

Source(1):